Illumina® | The NovaSeq™ 6000Dx—The Future of Clinical Genomics is Here.

9 November 2022

The NovaSeq 6000Dx unleashes a new era for the clinical laboratory. Capable of generating more than 6 Tb of data in less than two days, it delivers powerful and scalable high-throughput next-generation sequencing (NGS) in an FDA-registered, CE-marked platform for in vitro diagnostic (IVD) applications. With a unified user interface that enables seamless control of both IVD and RUO Modes and a dedicated DRAGEN™ Server for accelerated data analysis, the NovaSeq 6000Dx instrument delivers high-quality results for both clinical and research applications. The future of clinical genomics is here. Learn more at www.illumina.com/NovaSeq6000Dx For In Vitro Diagnostic Use. Not available in all regions and countries. #illumina #NovaSeq6000Dx #DRAGEN #ClinicalGenomics Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

Share this article on